Saliva diagnostics: Utilizing oral fluids to determine health status

Monographs in Oral Science

Volumn 24, Issue , 2014, Pages 88-98

  Schafer, Christopher A ^a   Schafer, Jason J ^b   Yakob, Maha ^a   Lima, Patricia ^a   Camargo, Paulo ^a   Wong, David T W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ARTICLE; CHEMISTRY; DIAGNOSIS; EARLY DIAGNOSIS; HEALTH STATUS; HUMAN; METABOLOMICS; MICROFLORA; MOUTH DISEASE; PROTEOMICS; SALIVA;

BIOLOGICAL MARKERS; DIAGNOSIS; EARLY DIAGNOSIS; HEALTH STATUS; HUMANS; METABOLOMICS; MICROBIOTA; MOUTH DISEASES; PROTEOMICS; SALIVA; TRANSCRIPTOME;

EID: 84904620929     PISSN: 00770892     EISSN: 16623843     Source Type: Book Series    
DOI: 10.1159/000358791     Document Type: Article

References (57)

1. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD: Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Ins 2008; 100: 1432-1438.
2. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, Bassilian S, Bedi GS, Boontheung P, Cociorva D, Delahunty CM, Denny T, Dunsmore J, Faull KF, Gilligan J, Gonzalez-Begne M, Halgand F, Hall SC, Han X, Henson B, Hewel J, Hu S, Jeffrey S, Jiang J, Loo JA, Ogorzalek Loo RR, Malamud D, Melvin JE, Miroshnychenko O, Navazesh M, Niles R, Park SK, Prakobphol A, Ramachandran P, Richert M, Robinson S, Sondej M, Souda P, Sullivan MA, Takashima J, Than S, Wang J, Whitelegge JP, Witkowska HE, Wolinsky L, Xie Y, Xu T, Yu W, Ytterberg J, Wong DT, Yates JR 3rd, Fisher SJ: The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008; 7: 1994-2006.
3. Hu S, Loo JA, Wong DT: Human Saliva Proteome Analysis. Ann NY Acad Sci 2007; 1098: 323-329.
4. Kawas SA, Rahim ZHA, Ferguson DB: Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol 2012; 57: 1-9.
5. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA, Wong DT: Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis- mass spectrometry. Proteomics 2005; 5: 1714-1728.
6. Schulz BL, Cooper-White J, Punyadeera CK: Saliva proteome research: current status and future outlook. Crit Rev Biotechnol 2013; 33: 246-259.
7. Paster BJ, Dewhirst FE: Molecular microbial diagnosis. Periodontol 2000 2009; 51: 38-44.
8. Takeshita T, Suzuki N, Nakano Y, Shimazaki Y, Yoneda M, Hirofuji T, Yamashita Y: Relationship between oral malodor and the global composition of indigenous bacterial populations in saliva. Appl Environm Microbiol 2010; 76: 2806-2814.
9. Yang F, Zeng X, Ning K, Liu K-L, Lo C-C, Wang W, Chen J, Wang D, Huang R, Chang X, Chain PS, Xie G, Ling J, Xu J: Saliva microbiomes distinguish cariesactive from healthy human populations. ISME J 2012; 6: 1-10.
10. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
11. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
12. Brinkmann O, Wong DT: Salivary transcriptome biomarkers in oral squamous cell cancer detection. Adv Clin Chem 2011; 55: 21-34.
13. Hu S, Vissink A, Arellano M, Roozendaal C, Zhou H, Kallenberg CGM, Wong DT: Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays. Proteomics 2011; 11: 1499-1507.
14. Lee H, Park M, Choi A, An J, Yang W, Shin K-J: Potential forensic application of DNA methylation profiling to body fluid identification. Int J Legal Med 2012; 126: 55-62.
15. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong D: Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010; 138: 949-957.
16. Spielmann N, Ilsley D, Gu J, Lea K, Brockman J, Heater S, Setterquist R, Wong DTW: The human salivary RNA transcriptome revealed by massively parallel sequencing. Clin Chem 2012; 58: 1314-1321.
17. Vasilatou D, Papageorgiou S, Dimitriadis G, Pappa V: Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes. Epigenetics 2013; 8: 561-570.
18. Ohgane J, Yagi S, Shiota K: Epigenetics: the DNA methylation profile of tissuedependent and differentially methylated regions in cells. Placenta 2008; 29(suppl): 29-35.
19. Grønbæk K, Hother C, Jones PA: Epigenetic changes in cancer. APMIS 2007; 115: 1039-1059.
20. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054.
21. Viet CT, Schmidt BL: Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev 2008; 17: 3603-3611.
22. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang W-W, Kim MM, Claybourne Q, Goldenberg D, Khan Z, Khan T, Westra WH, Sidransky D, Koch W, Califano JA: Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res 2011; 17: 4782-4789.
23. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA: The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PloS One 2009; 4:e6767.
24. Bocklandt S, Lin W, Sehl ME, Sánchez F, Sinsheimer JS, Horvath S, Vilain E: Epigenetic predictor of age. PloS One 2011; 6:e14821.
25. Lee Y-H, Kim J, Zhou H, Kim B, Wong D: Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med 2012; 90: 427-434.
26. United States Food and Drug Administration: First rapid home-use HIV kit approved for self-testing. FDA Consumer Health Information 2012. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM311690.pdf (accessed May 6, 2013).
27. Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, Wu J, Wen SW: Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infect Dis 2009; 13: 20-23.
28. Gonzalez V, Martro E, Folch C, Esteve A, Matas L, Montoliu A, Grifols JR, Bolao F, Tural C, Muga R, Parry JV, Ausina V, Casabona J: Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur J Clin Microbiol Infect Dis 2008; 27: 121-126.
29. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, Lakshmanan A, Wade WG: The human oral microbiome. J Bacteriol 2010; 192: 5002-5017.
30. Keijser BJF, Zaura E, Huse SM, van der Vossen JMBM, Schuren FHJ, Montijn RC, ten Cate JM, Crielaard W: Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res 2008; 87: 1016-1020.
31. Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DT: Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012; 61: 582-588.
32. Jordan KW, Nordenstam J, Lauwers GY, Rothenberger DA, Alavi K, Garwood M, Cheng LL: Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum 2009; 52: 520-525.
33. Walsh MC, Brennan L, Malthouse JPG, Roche HM, Gibney MJ: Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 2006; 84: 531-539.
34. Barnes VM, Ciancio SG, Shibly O, Xu T, Devizio W, Trivedi HM, Guo L, Jönsson TJ: Metabolomics reveals elevated macromolecular degradation in periodontal disease. J Dent Res 2011; 90: 1293-1297.
35. Sugimoto M, Wong D, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010; 6: 78-95.
36. Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W: Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2011; 129: 2207-2217.
37. Yan S-K, Wei B-J, Lin Z-Y, Yang Y, Zhou Z-T, Zhang W-D: A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol 2008; 44: 477-483.
38. Wang L: Pharmacogenomics: a systems approach. Wiley Interdiscip Rev Syst Biol Med 2010; 2: 3-22.
39. Chen X, Liang H, Zhang J, Zen K, Zhang C-Y: Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 2012; 22: 125-132.
40. Thery C, Ostrowski M, Segura E: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
41. Pant S, Hilton H, Burczynski ME: The multifaceted exosome: BIogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012; 83: 1484-1494.
42. Bellingham SA, Guo B, Coleman B, Hill AF: Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol 2012; 3: 124.
43. Hood JL, San RS, Wickline SA: Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011; 71: 3792-3801.
44. Yang C, Robbins PD: The roles of tumor- derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011; 2011: 11.
45. Fleischhacker M, Schmidt B: Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007; 1775: 181-232.
46. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-17452.
47. O'Driscoll L: Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers. Anticancer Res 2007; 27: 1257-1265.
48. Dinger ME, Mercer TR, Mattick JS: RNAs as extracellular signaling molecules. J Mol Endocrinol 2008; 40: 151-159.
49. Scott WG: Ribozymes. Curr Opin Struct Biol 2007; 17: 280-286.
50. Lässer C, Eldh M, Lötvall J: Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012; 59:e3037.
51. Record M, Subra C, Silvente-Poirot S, Poirot M: Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 2011; 81: 1171-1182.
52. Vlassov AV, Magdaleno S, Setterquist R, Conrad R: Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820: 940-948.
53. Dimov I, Jankovic Velickovic L, Stefanovic V: Urinary exosomes. Sci Wrld J 2009; 9: 1107-1118.
54. Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-579.
55. Lakkaraju A, Rodriguez-Boulan E: Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol 2008; 18: 199-209.
56. Pegtel DM, van de Garde MDB, Middeldorp JM: Viral miRNAs exploiting the endosomal/exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta 2011; 1809: 715-721.
57. Lau CS, Wong DTW: Breast cancer exosome- like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 2012; 7:e33037